<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00556777</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000574074</org_study_id>
    <secondary_id>CLCC-IORT-Sein</secondary_id>
    <secondary_id>INCA-RECF0284</secondary_id>
    <nct_id>NCT00556777</nct_id>
  </id_info>
  <brief_title>Radiation Therapy During Surgery in Treating Older Women With Stage I Breast Cancer</brief_title>
  <official_title>Phase 2 Study Evaluating the Feasibility and the Reproducibility of Concentrated Radiotherapy and Focalized Electrontherapy During Surgery for the Treatment of Older Patients With Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut du Cancer de Montpellier - Val d'Aurelle</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving&#xD;
      intraoperative radiation therapy may reduce the amount of normal tissue that needs to be&#xD;
      removed.&#xD;
&#xD;
      PURPOSE: This phase II trial is studying how well giving radiation therapy during surgery&#xD;
      works in treating older women with stage I breast cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
      Primary&#xD;
&#xD;
        -  Study the feasibility and reproducibility of intraoperative radiotherapy as the only&#xD;
           treatment after lumpectomy in older women with stage I breast cancer.&#xD;
&#xD;
      Secondary&#xD;
&#xD;
        -  Study the impact of this regimen on maintaining self-care.&#xD;
&#xD;
        -  Study the quality of life (QLQ-C30) and satisfaction with care.&#xD;
&#xD;
        -  Study regimen tolerance and cosmetic results.&#xD;
&#xD;
        -  Evaluate the economic impact of this treatment.&#xD;
&#xD;
        -  Study relapse-free and disease-specific survival.&#xD;
&#xD;
      OUTLINE: Patients undergo conservative breast surgery and axillary node dissection (sentinel&#xD;
      node or classic resection). At this point, patients must have either negative axillary lymph&#xD;
      nodes after removal of ≥ 6 lymph nodes, negative sentinel nodes, or have had a limited&#xD;
      lumpectomy with negative margins ≥ 2 mm. Patients undergo intraoperative radiotherapy during&#xD;
      surgery, before closing and reconstruction of the breast.&#xD;
&#xD;
      Patients may begin hormonal therapy after completing study therapy.&#xD;
&#xD;
      After completion of study therapy, patients are followed every 3 months for 1 year, every 4&#xD;
      months for 1 year, and then every 6 months for 3 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Reproducibility</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life (QLQ-C30)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with care</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerability</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cosmetic results</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Economic impact</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free survival</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease-specific survival</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Breast Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>axillary lymph node dissection</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional surgery</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sentinel lymph node biopsy</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>intraoperative radiation therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          -  Histologically confirmed stage I breast cancer&#xD;
&#xD;
               -  Size ≤ 20 mm (by ultrasound), N0, any quadrant&#xD;
&#xD;
          -  Hormone receptor status not specified&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Distant metastases&#xD;
&#xD;
          -  Inflammatory breast cancer&#xD;
&#xD;
          -  Lobular in situ disease&#xD;
&#xD;
          -  Invasive cancer or ductal carcinoma in situ&#xD;
&#xD;
          -  Nonepithelial disease or sarcoma&#xD;
&#xD;
          -  Multicentric disease&#xD;
&#xD;
          -  Lymphatic embolism&#xD;
&#xD;
          -  Margins of safety unknown or positive (in situ or invasive)&#xD;
&#xD;
          -  Preoperative mammography showing diffuse microcalcification&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  Menopausal&#xD;
&#xD;
          -  Karnofsky 70-100%&#xD;
&#xD;
          -  No other prior cancer except basal cell skin cancer, uterine epithelioma in situ, or&#xD;
             other cancer in complete remission for the past 5 years&#xD;
&#xD;
          -  No geographic, social, or psychiatric reasons that would impede participation in study&#xD;
             treatment&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
          -  See Disease Characteristics&#xD;
&#xD;
          -  No prior neoadjuvant therapy&#xD;
&#xD;
          -  No concurrent participation in another study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Bernard Dubois, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Institut du Cancer de Montpellier - Val d'Aurelle</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle</name>
      <address>
        <city>Montpellier</city>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <study_first_submitted>November 9, 2007</study_first_submitted>
  <study_first_submitted_qc>November 9, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 12, 2007</study_first_posted>
  <last_update_submitted>May 12, 2011</last_update_submitted>
  <last_update_submitted_qc>May 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2011</last_update_posted>
  <keyword>stage I breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

